List of Tables
Table 1. Global GP Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GP Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global GP Vaccination Market Competitive Situation by Manufacturers in 2024
Table 4. Global GP Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global GP Vaccination Sales Market Share by Manufacturers (2020-2025)
Table 6. Global GP Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global GP Vaccination Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market GP Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of GP Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GP Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GP Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of GP Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GP Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GP Vaccination as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GP Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global GP Vaccination Sales by Region (2020-2025) & (K Units)
Table 18. Global GP Vaccination Sales Market Share by Region (2020-2025)
Table 19. Global GP Vaccination Sales by Region (2026-2031) & (K Units)
Table 20. Global GP Vaccination Sales Market Share by Region (2026-2031)
Table 21. Global GP Vaccination Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global GP Vaccination Revenue Market Share by Region (2020-2025)
Table 23. Global GP Vaccination Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global GP Vaccination Revenue Market Share by Region (2026-2031)
Table 25. North America GP Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America GP Vaccination Sales by Country (2020-2025) & (K Units)
Table 27. North America GP Vaccination Sales by Country (2026-2031) & (K Units)
Table 28. North America GP Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America GP Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe GP Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe GP Vaccination Sales by Country (2020-2025) & (K Units)
Table 32. Europe GP Vaccination Sales by Country (2026-2031) & (K Units)
Table 33. Europe GP Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe GP Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific GP Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific GP Vaccination Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific GP Vaccination Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific GP Vaccination Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific GP Vaccination Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America GP Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America GP Vaccination Sales by Country (2020-2025) & (K Units)
Table 42. Latin America GP Vaccination Sales by Country (2026-2031) & (K Units)
Table 43. Latin America GP Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America GP Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa GP Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa GP Vaccination Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa GP Vaccination Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa GP Vaccination Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa GP Vaccination Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global GP Vaccination Sales (K Units) by Type (2020-2025)
Table 51. Global GP Vaccination Sales (K Units) by Type (2026-2031)
Table 52. Global GP Vaccination Sales Market Share by Type (2020-2025)
Table 53. Global GP Vaccination Sales Market Share by Type (2026-2031)
Table 54. Global GP Vaccination Revenue (US$ Million) by Type (2020-2025)
Table 55. Global GP Vaccination Revenue (US$ Million) by Type (2026-2031)
Table 56. Global GP Vaccination Revenue Market Share by Type (2020-2025)
Table 57. Global GP Vaccination Revenue Market Share by Type (2026-2031)
Table 58. Global GP Vaccination Price (US$/Unit) by Type (2020-2025)
Table 59. Global GP Vaccination Price (US$/Unit) by Type (2026-2031)
Table 60. Global GP Vaccination Sales (K Units) by Application (2020-2025)
Table 61. Global GP Vaccination Sales (K Units) by Application (2026-2031)
Table 62. Global GP Vaccination Sales Market Share by Application (2020-2025)
Table 63. Global GP Vaccination Sales Market Share by Application (2026-2031)
Table 64. Global GP Vaccination Revenue (US$ Million) by Application (2020-2025)
Table 65. Global GP Vaccination Revenue (US$ Million) by Application (2026-2031)
Table 66. Global GP Vaccination Revenue Market Share by Application (2020-2025)
Table 67. Global GP Vaccination Revenue Market Share by Application (2026-2031)
Table 68. Global GP Vaccination Price (US$/Unit) by Application (2020-2025)
Table 69. Global GP Vaccination Price (US$/Unit) by Application (2026-2031)
Table 70. Moderna Company Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Moderna GP Vaccination Product
Table 74. Moderna Recent Developments/Updates
Table 75. CanSino Biologicals Company Information
Table 76. CanSino Biologicals Description and Business Overview
Table 77. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. CanSino Biologicals GP Vaccination Product
Table 79. CanSino Biologicals Recent Developments/Updates
Table 80. Inovio Pharmaceuticals Company Information
Table 81. Inovio Pharmaceuticals Description and Business Overview
Table 82. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Inovio Pharmaceuticals GP Vaccination Product
Table 84. Inovio Pharmaceuticals Recent Developments/Updates
Table 85. Shenzhen Geno-Immune Medical Institute Company Information
Table 86. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 87. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shenzhen Geno-Immune Medical Institute GP Vaccination Product
Table 89. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
Table 90. GlaxoSmithKine Company Information
Table 91. GlaxoSmithKine Description and Business Overview
Table 92. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKine GP Vaccination Product
Table 94. GlaxoSmithKine Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer GP Vaccination Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson＆Johnson Company Information
Table 101. Johnson＆Johnson Description and Business Overview
Table 102. Johnson＆Johnson GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Johnson＆Johnson GP Vaccination Product
Table 104. Johnson＆Johnson Recent Developments/Updates
Table 105. Heat Biologics Company Information
Table 106. Heat Biologics Description and Business Overview
Table 107. Heat Biologics GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Heat Biologics GP Vaccination Product
Table 109. Heat Biologics Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi GP Vaccination Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Takis Biotech Company Information
Table 116. Takis Biotech Description and Business Overview
Table 117. Takis Biotech GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Takis Biotech GP Vaccination Product
Table 119. Takis Biotech Recent Developments/Updates
Table 120. Zydus Cadila Company Information
Table 121. Zydus Cadila Description and Business Overview
Table 122. Zydus Cadila GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Zydus Cadila GP Vaccination Product
Table 124. Zydus Cadila Recent Developments/Updates
Table 125. Codagenix Company Information
Table 126. Codagenix Description and Business Overview
Table 127. Codagenix GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Codagenix GP Vaccination Product
Table 129. Codagenix Recent Developments/Updates
Table 130. GeoVax Company Information
Table 131. GeoVax Description and Business Overview
Table 132. GeoVax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. GeoVax GP Vaccination Product
Table 134. GeoVax Recent Developments/Updates
Table 135. Bravovax Company Information
Table 136. Bravovax Description and Business Overview
Table 137. Bravovax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bravovax GP Vaccination Product
Table 139. Bravovax Recent Developments/Updates
Table 140. Altimmune Company Information
Table 141. Altimmune Description and Business Overview
Table 142. Altimmune GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Altimmune GP Vaccination Product
Table 144. Altimmune Recent Developments/Updates
Table 145. Vaxart Company Information
Table 146. Vaxart Description and Business Overview
Table 147. Vaxart GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Vaxart GP Vaccination Product
Table 149. Vaxart Recent Developments/Updates
Table 150. Clover Biopharmaceuticals Company Information
Table 151. Clover Biopharmaceuticals Description and Business Overview
Table 152. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Clover Biopharmaceuticals GP Vaccination Product
Table 154. Clover Biopharmaceuticals Recent Developments/Updates
Table 155. ImmunoPrecise Company Information
Table 156. ImmunoPrecise Description and Business Overview
Table 157. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. ImmunoPrecise GP Vaccination Product
Table 159. ImmunoPrecise Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. GP Vaccination Distributors List
Table 163. GP Vaccination Customers List
Table 164. GP Vaccination Market Trends
Table 165. GP Vaccination Market Drivers
Table 166. GP Vaccination Market Challenges
Table 167. GP Vaccination Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of GP Vaccination
Figure 2. Global GP Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GP Vaccination Market Share by Type: 2024 & 2031
Figure 4. DNA Product Picture
Figure 5. Non-replicating Viral Vector Product Picture
Figure 6. Protein Subunit Product Picture
Figure 7. RNA Product Picture
Figure 8. Others Product Picture
Figure 9. Global GP Vaccination Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global GP Vaccination Market Share by Application: 2024 & 2031
Figure 11. Adults
Figure 12. Children
Figure 13. Global GP Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global GP Vaccination Market Size (2020-2031) & (US$ Million)
Figure 15. Global GP Vaccination Sales (2020-2031) & (K Units)
Figure 16. Global GP Vaccination Average Price (US$/Unit) & (2020-2031)
Figure 17. GP Vaccination Report Years Considered
Figure 18. GP Vaccination Sales Share by Manufacturers in 2024
Figure 19. Global GP Vaccination Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest GP Vaccination Players: Market Share by Revenue in GP Vaccination in 2024
Figure 21. GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global GP Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America GP Vaccination Sales Market Share by Country (2020-2031)
Figure 24. North America GP Vaccination Revenue Market Share by Country (2020-2031)
Figure 25. U.S. GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe GP Vaccination Sales Market Share by Country (2020-2031)
Figure 28. Europe GP Vaccination Revenue Market Share by Country (2020-2031)
Figure 29. Germany GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific GP Vaccination Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific GP Vaccination Revenue Market Share by Region (2020-2031)
Figure 36. China GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America GP Vaccination Sales Market Share by Country (2020-2031)
Figure 44. Latin America GP Vaccination Revenue Market Share by Country (2020-2031)
Figure 45. Mexico GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa GP Vaccination Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa GP Vaccination Revenue Market Share by Country (2020-2031)
Figure 50. Turkey GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE GP Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of GP Vaccination by Type (2020-2031)
Figure 54. Global Revenue Market Share of GP Vaccination by Type (2020-2031)
Figure 55. Global GP Vaccination Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of GP Vaccination by Application (2020-2031)
Figure 57. Global Revenue Market Share of GP Vaccination by Application (2020-2031)
Figure 58. Global GP Vaccination Price (US$/Unit) by Application (2020-2031)
Figure 59. GP Vaccination Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
